Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Mostafa Z. Badr"'
Autor:
Mostafa Z. Badr
Publikováno v:
PPAR Research, Vol 2009 (2009)
Externí odkaz:
https://doaj.org/article/6dc1fc639da14c5287681f698df9cacb
Autor:
Mostafa Z. Badr, Alexander Shnyra, Mikhail Zoubine, Maxim Norkin, Betty Herndon, Tim Quinn, Roberto N. Miranda, Michael L. Cunningham, Agostino Molteni
Publikováno v:
PPAR Research, Vol 2007 (2007)
Infection with Mycobacterium tuberculosis (TB) induces pulmonary immunopathology mediated by classical Th1 type of acquired immunity with hepatic involvement in up to 80% of disseminated cases. Since PPAR agonists cause immune responses characterized
Externí odkaz:
https://doaj.org/article/3328e255bd34497b80782c0ea16ec52e
Autor:
Yu-Jui Yvonne Wan, Mostafa Z. Badr
Publikováno v:
PPAR Research, Vol 2006 (2006)
It has been proposed that PPAR-dependent, accelerated catabolism of proinflammatory mediators may contribute to the fast resolution of inflammation. Because retinoid X receptors are obligate heterodimer partners of PPARs, we investigated the impact o
Externí odkaz:
https://doaj.org/article/67cfebf8ce60488cb97378124b5e71ec
Publikováno v:
The Scientific World Journal, Vol 1, Pp 85-85 (2001)
Externí odkaz:
https://doaj.org/article/2625f881b8dc499db55b47a4c787eb7f
Autor:
Mostafa Z. Badr
Publikováno v:
Egyptian Journal of Basic and Clinical Pharmacology, Vol 8, Pp 1-3 (2019)
There is no abstract for this article.
Autor:
Mostafa Z. Badr
Nuclear receptors are ligand activated transcription factors that control numerous biological functions. Consequently, altering activity of these receptors is proposed, and indeed documented, to affect many physiological and pathological conditions i
Autor:
Mostafa Z. Badr
Publikováno v:
Egyptian Journal of Basic and Clinical Pharmacology, Vol 8, Pp 1-3 (2018)
There is no abstract for this article.
Autor:
Mostafa Z. Badr, Jihan Youssef
Publikováno v:
Nuclear Receptor Research, Vol 2, Pp 1-30 (2015)
In this review, the history of the peroxisome proliferator-activated receptors (PPARα, PPARβ/δ and PPARγ) discovery is briefly traced and major features of their structure and posttranslational modifications are presented. Furthermore, an overvie
Publikováno v:
Journal of Heavy Metal Toxicity and Diseases. 1
Fibrates are the only marketed PPARα ligands that are effective in lowering triglycerides. Their chemical structures are characterized by the presence of the 2-phenoxy-2-methylpropanoic acid moiety. Clofibric acid (CA) is a known ligand for PPARα.